Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Stress Ball and Empathic Verbal-Tactile Interventions for Reducing Anxiety and Pain in Mammography and Breast Ultrasonography: A Randomized Trial

25. April 2026 aktualisiert von: Betül Güven, Istanbul University

Effects of Stress Ball Use and Empathic Verbal Communication With Therapeutic Touch on Anxiety and Pain Perception in Women Undergoing Mammography and Breast Ultrasonography: A Randomized Controlled Trial

This prospective, randomized controlled trial aims to determine the effects of stress ball use and empathic verbal communication with therapeutic touch on anxiety and pain perception in women undergoing mammography and breast ultrasonography. The study will be conducted between May and September 2026 at Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital.

A total of 122 women meeting the inclusion criteria will be randomly assigned into three groups: stress ball group (n=41), empathic verbal communication with touch group (n=41), and control group (n=40). Women in the stress ball group will be instructed to use a soft stress ball before and during the procedure. Participants in the empathic verbal-tactile group will receive structured verbal empathy combined with therapeutic touch. The control group will receive routine care without additional intervention.

Data will be collected before and after the procedures using a Descriptive Characteristics Form, the State-Trait Anxiety Inventory, and a Numerical Rating Scale for pain assessment. The findings of this study are expected to provide evidence on the effectiveness of non-pharmacological interventions in reducing anxiety and pain during breast imaging procedures.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This study is designed as a prospective, parallel-group randomized controlled trial to examine the effects of stress ball use and empathic verbal communication combined with therapeutic touch on anxiety levels and pain perception in women undergoing mammography and breast ultrasonography. The research will be carried out between May and September 2026 at Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital.

Prior to participant recruitment, all necessary ethical approvals will be secured. Eligible women presenting for mammography and breast ultrasonography will be informed about the study purpose, procedures, and voluntary nature of participation, and written informed consent will be obtained. Inclusion criteria consist of being 18 years of age or older, undergoing these imaging procedures for the first time, being literate, and having no sensory or motor impairment affecting the upper extremities. Women with previous experience of these procedures, as well as those with cognitive, physical, visual, or hearing impairments, will be excluded.

The sample size was determined as 122 participants based on a 95% confidence level and 5% margin of error. Participants will be allocated into three groups in a 1:1:1 ratio: stress ball group (n=41), empathic verbal communication with therapeutic touch group (n=41), and control group (n=40).

Randomization and Allocation Procedure Participants will be randomized individually on the day of their scheduled mammography and breast ultrasonography appointments. After confirming eligibility and obtaining written informed consent, participants will be assigned to one of three groups (stress ball, empathic verbal communication with therapeutic touch, or control) using a computer-generated randomization sequence.

Block randomization with a 1:1:1 allocation ratio will be used to ensure balanced group sizes throughout the study period. The randomization list will be prepared in advance by an independent researcher who is not involved in recruitment, intervention delivery, or data collection.

To maintain allocation concealment, group assignments will be placed in sequentially numbered, opaque, sealed envelopes. These envelopes will be opened only after participant enrollment, in the order of inclusion.

Randomization will be implemented continuously on a daily basis as participants present for their scheduled appointments, ensuring that group assignment remains unpredictable and independent of appointment timing.

Due to the nature of the interventions, blinding of participants and intervention providers is not feasible. However, outcome data will be collected using standardized and validated self-report instruments to minimize bias.

Intervention Procedures Participants assigned to the stress ball group will be provided with a soft, smooth stress ball (6 cm in diameter) and instructed to repeatedly squeeze and relax it while waiting for the procedure and during ultrasonography.

Participants in the empathic verbal communication with therapeutic touch group will be taken to a quiet waiting area. Trained researchers will use predefined empathic statements and simultaneously apply gentle touch by placing a hand on the participant's shoulder.

Participants in the control group will receive routine clinical care without any additional intervention.

Data Collection and Outcomes Data will be collected immediately before and after the imaging procedures. A Descriptive Characteristics Form will be used to obtain sociodemographic and clinical information. Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI), and pain intensity will be measured using a Numerical Rating Scale ranging from 0 (no pain) to 10 (worst possible pain).

The primary aim of the study is to evaluate the effectiveness of these non-pharmacological interventions in reducing anxiety and perceived pain during breast imaging procedures.

Data Analysis Statistical analyses will be conducted using statistical software. Descriptive statistics will summarize baseline characteristics. Between-group differences in anxiety and pain scores will be assessed using appropriate tests based on data distribution (e.g., one-way ANOVA or Kruskal-Wallis test), while within-group changes will be analyzed using paired comparisons. Post hoc analyses will be performed where applicable. Statistical significance will be set at p < 0.05.

Studientyp

Interventionell

Einschreibung (Geschätzt)

122

Phase

  • Unzutreffend

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Female participants aged 18 years and older
  • Scheduled to undergo mammography and breast ultrasonography
  • Undergoing these imaging procedures for the first time
  • Literate (able to read and understand study materials)
  • No sensory or motor impairment affecting the upper extremities (hands/arms)
  • Willing to participate and able to provide written informed consent

Exclusion Criteria:

  • Previous experience of mammography or breast ultrasonography
  • Presence of any cognitive impairment that may affect understanding or communication
  • Presence of any physical disability that may interfere with participation
  • Hearing or visual impairment that may hinder communication or completion of study procedures
  • Refusal to participate or inability to provide informed consent

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Stress Ball Intervention
Participants in this group will be provided with a soft, smooth stress ball (approximately 6 cm in diameter) before the imaging procedure. They will be instructed to rhythmically squeeze and relax the ball while waiting for the procedure and to continue its use during breast ultrasonography.
Participants will be provided with a soft, smooth stress ball (approximately 6 cm in diameter) prior to the imaging procedure. They will be instructed to rhythmically squeeze and release the ball while waiting for mammography and to continue using it during breast ultrasonography until the procedure is completed.
Experimental: Empathic Verbal Communication with Therapeutic Touch
Participants in this group will be guided to a quiet waiting area where trained researchers will deliver standardized empathic verbal statements. Simultaneously, gentle therapeutic touch will be applied by placing a hand on the participant's shoulder to provide reassurance and emotional support prior to the procedure.
Empathic Verbal Communication with Therapeutic Touch (Behavioral) Participants will be taken to a quiet waiting area before the procedure. Trained researchers will deliver standardized empathic verbal statements to provide reassurance and emotional support. At the same time, gentle therapeutic touch will be applied by placing a hand on the participant's shoulder. The intervention will be administered prior to the imaging procedure.
Kein Eingriff: Control (Routine Care)
Participants in the control group will receive routine clinical care without any additional intervention beyond standard practice.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Anxiety Level
Zeitfenster: Immediately before and immediately after mammography and breast ultrasonography (same day)
Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI). Higher scores indicate higher levels of anxiety
Immediately before and immediately after mammography and breast ultrasonography (same day)
Pain Intensity
Zeitfenster: Immediately after mammography and breast ultrasonography (same day)
Pain intensity will be evaluated using a Numerical Rating Scale (0-10), where 0 indicates no pain and 10 indicates the worst possible pain.
Immediately after mammography and breast ultrasonography (same day)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

4. Mai 2026

Primärer Abschluss (Geschätzt)

14. September 2026

Studienabschluss (Geschätzt)

30. September 2026

Studienanmeldedaten

Zuerst eingereicht

25. April 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

25. April 2026

Zuerst gepostet (Tatsächlich)

1. Mai 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

1. Mai 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

25. April 2026

Zuletzt verifiziert

1. April 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2025/67

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .